Whole-Brain Three-Dimensional Profiling Reveals Brain Region Specific Axon Vulnerability in 5xFAD Mouse Model

Jianping Zhang, Ben Long, Anan Li, Qingtao Sun, Jiaojiao Tian, Ting Luo, Zhangheng Ding, Hui Gong, Xiangning LiFrontiers in Neuroanatomy 2020 · DOI

TL;DR

This study maps the early-stage progression of axonopathy in the 5xFAD mouse model of Alzheimer's disease using whole-brain 3D imaging. They discovered that axon damage begins in specific brain regions (lateral septal nucleus, subiculum, and medial mammillary nucleus) before widespread pathology, highlighting the subiculum-medial mammillary nucleus pathway as particularly vulnerable and potentially linked to early cognitive deficits.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is characterized by neurodegeneration, and a key pathological feature is axonopathy – damage to the long, slender projections of neurons. While axonopathy is known to occur in AD patients and animal models, its precise temporal and regional progression, especially in the early stages, has been unclear. Understanding this progression is crucial for identifying when and where interventions might be most effective. Previous studies often relied on 2D imaging or focused on limited brain areas, leaving a gap in our understanding of how axon damage unfolds across the entire brain over time. This paper aims to fill this gap by creating a comprehensive 3D map of early-stage axonopathy in a well-established AD mouse model.

Methods

The researchers employed a combination of advanced imaging and tracing techniques:

  • Fluorescence Micro-Optical Sectioning Tomography (fMOST): This is the core imaging technique. fMOST allows for high-resolution (0.32 x 0.32 x 2 µm³) whole-brain imaging, enabling the reconstruction of neural structures in three dimensions. This is a significant advancement over traditional 2D imaging for studying complex brain-wide phenomena.
  • 5xFAD/Thy1-GFP-M Mice: This transgenic mouse model is crucial. The 5xFAD component rapidly develops amyloid pathology and AD-like symptoms, while the Thy1-GFP-M component genetically labels neurons with green fluorescent protein (GFP), allowing their axons to be visualized.
  • Rabies Virus (RV) Tracing: To pinpoint the origin of vulnerable axons, RV tracing was used. This technique allows for retrograde tracing, meaning it can identify the neurons that project to a specific injection site. In this study, RV was injected into the medial mammillary nucleus (MM) to identify its projecting neurons.
  • Immunohistochemistry: Standard techniques were used to label specific cell types (e.g., NeuN for neurons) to complement the imaging and tracing data.
  • Behavioral Assays: Open Field Test (OFT), Novel Object Recognition Test (ORT), and Object-Location Memory Test (OLT) were conducted to assess cognitive function at different ages.

Datasets

The study utilized data from:

  • 5xFAD/Thy1-GFP-M mice: These mice served as the primary model for studying axonopathy.
  • Thy1-GFP-M mice: Used as a control group to establish baseline GFP-labeled axonal structures.
  • C57 mice: Used as a control group for behavioral assays and rabies tracing.

The researchers generated novel whole-brain 3D datasets of GFP-labeled axons at various time points (6, 7, 8, and 16 weeks old) in the 5xFAD/GFP mice. This constitutes a new dataset for studying early-stage AD pathology.

Key Insights and Ideas

  • Early, Region-Specific Axonopathy: Axonopathy doesn't appear randomly. It first emerges in specific, interconnected brain regions (LS, SUB, MM) at a surprisingly early age (7 weeks old), predating widespread pathology.
  • The SUB-MM Pathway is a Vulnerable Hub: The subiculum (SUB) to medial mammillary nucleus (MM) pathway is identified as particularly susceptible to early axon damage. This pathway is critical for memory and cognitive functions.
  • Dynamic Axonopathy in the MM: Interestingly, while axonopathy increases in most brain regions with age, it significantly decreases in the MM after 8 weeks old. This suggests a complex dynamic where initial damage might be followed by some form of resolution or compensatory mechanism, or perhaps rapid degeneration leading to loss of observable varicosities.
  • Amyloid-Beta Plaques Precede and Correlate with Axonopathy: The study found that amyloid-beta plaques appear in the SUB before axonopathy, and axonopathy often occurs in close proximity to these plaques, suggesting a causal or contributing role.
  • Axonopathy Precedes Behavioral Deficits: The identified vulnerable pathways (SUB-MM) show signs of damage before the onset of significant behavioral impairments, underscoring the potential for early therapeutic intervention.

Key Results

  • Spatiotemporal Map: The study successfully created a detailed 3D map of axonopathy progression in the 5xFAD mouse model.
  • Early Onset: Axonopathy was first observed in the lateral septal nucleus (LS), subiculum (SUB), and medial mammillary nucleus (MM) at 7 weeks old.
  • Regional Differences: Axonopathy increased in most brain regions from 8 to 16 weeks old, but significantly decreased in the MM during the same period.
  • SUB-MM Vulnerability: Axons projecting from the SUB to the MM were found to be particularly vulnerable, showing damage prior to behavioral deficits.
  • Behavioral Impairment: 16-week-old 5xFAD mice showed impaired novel-object recognition and object-location memory, but not at 8 weeks old, aligning with the observed early axonal damage.

Limitations and Future Work

  • Mouse Model Specificity: While the 5xFAD model is valuable, it's an artificial construct. The study acknowledges that the progression of axonopathy might be influenced by both amyloid-beta deposition and the overexpression of APP, and that this model may not perfectly replicate the complex, multi-pathology development seen in human AD over decades.
  • Thy1-GFP-M Labeling: The authors note that the Thy1-GFP-M line can sometimes show Golgi staining-like labeling and may not provide strong cortical labeling, potentially limiting the complete capture of all axonopathy.
  • Mechanisms of MM Axonopathy Decrease: The significant decrease in MM axonopathy after 8 weeks warrants further investigation to understand the underlying mechanisms.
  • Therapeutic Translation: The authors emphasize that while these findings provide insights into AD pathogenesis and potential therapeutic targets, applying this knowledge to human patients and clinical research requires further investigation. Future work could focus on understanding the specific functions of the SUB-MM pathway and how its dysfunction contributes to early AD symptoms, as well as exploring therapeutic strategies targeting these vulnerable circuits.

Summary updated

Abstract

Axonopathy is a pathological feature observed in both Alzheimer's disease (AD) patients and animal models. However, identifying the temporal and regional progression of axonopathy during AD development remains elusive. Using the fluorescence micro-optical sectioning tomography system, we acquired whole-brain datasets in the early stage of 5xFAD/Thy1-GFP-M mice. We reported that among GFP labeled axons, GFP-positive axonopathy first formed in the lateral septal nucleus, subiculum, and medial mammillary nucleus. The axonopathy further increased in most brain regions during aging. However, most of the axonopathic varicosities disappeared significantly in the medial mammillary nucleus after 8 weeks old. Continuous three-dimensional datasets showed that axonopathy in the medial mammillary nucleus was mainly located on axons from hippocampal GFP-positive neurons. Using the rabies viral tracer in combination with immunohistochemistry, we found that axons in the medial mammillary nucleus from the subiculum were susceptible to lesions that prior to the occurrence of behavioral disorders. In conclusion, we created an early-stage spatiotemporal map of axonopathy in 5xFAD/Thy1-GFP-M mice and identified specific neural circuits which are vulnerable to axon lesions in an AD mouse model. These findings underline the importance of early interventions for AD, and may contribute to the understanding of its progression and its early symptom treatment.
BibTeX
@inproceedings{zhang2020whole,
  author = {Jianping Zhang and Ben Long and Anan Li and Qingtao Sun and Jiaojiao Tian and Ting Luo and Zhangheng Ding and Hui Gong and Xiangning Li},
  title = {{Whole-Brain Three-Dimensional Profiling Reveals Brain Region Specific Axon Vulnerability in 5xFAD Mouse Model}},
  booktitle = {Frontiers in Neuroanatomy},
  year = {2020},
  doi = {10.3389/fnana.2020.608177},
}
Figure